Market opportunities lie in the expansion of medical weight loss programs, rising demand for GLP-1 drugs, and increased roles for physicians and bariatricians in weight management. With declining ...

Key market opportunities in weight loss and diet management include rising obesity, increasing demand for personalized ...

A University of Virginia School of Medicine researcher has received $3.4 million from the National Institutes of Health to increase the availability of weight-management programs that offer beneficial ...

Weight loss journeys are as unique as the individuals who embark on them. We all have different body types, lifestyles, health histories and goals that shape what we need to achieve lasting results.

Wegovy is a Food and Drug Administration-approved weight loss medication for people with obesity or those who are overweight with weight-related health conditions. In recent years, interest in ...

New research suggests intermittent fasting isn't all that great for weight loss. Experts break down the latest research.

News about intermittent fasting seems to change as frequently as the apps on your phone need upgrading. Yet another new study about the eating practice seeks to put doubts to rest after rounding up ...

TIX100 is a specific, orally available TXNIP inhibitor originally developed for its beta-cell protective effects in diabetes. It has received FDA Investigational New Drug approval in diabetes and ...

Share on Pinterest More exercise alone not enough to shift weight — reducing calories is essential, a new study suggests. Image credit: Aranel Vivarini/Stocksy The number of people with obesity has ...

A November 2025 Kaiser Family Foundation poll found that 1 in 8 U.S. adults have tried a GLP-1 medication for weight loss, diabetes or another condition. And we expect that number to rise now that one ...

Discovering the best protein bars for Weight Watchers can be a game-changer in your weight loss journey. These convenien ...